Billion-Dollar Bust: DOJ Unveils Largest Healthcare Fraud Takedown In U.S. History Story by Jack Kaminsky • 6h • 3 min read

 Billion-Dollar Bust: DOJ Unveils Largest Healthcare Fraud Takedown In U.S. History

After Novo and Lilly resolved GLP-1 shortages, where does the compounding industry stand? Experts weigh in By Fraiser Kansteiner Jun 27, 2025 10:36am

 After Novo and Lilly resolved GLP-1 shortages, where does the compounding industry stand? Experts weigh in | Fierce Pharma

 

Houston-based Empower Pharmacy fights Eli Lilly lawsuit over GLP-1 drugs

The Eli Lilly case against Empower Pharmacy tests a key strategy that's allowed compounding pharmacies to continue to produce versions of wildly popular...

.

1 week ago

Four more med spa licenses yanked over improper handling of cosmetic drugs By: Marty Schladen - June 23, 2025 4:50 am

 Four more med spa licenses yanked over improper handling of cosmetic drugs • Ohio Capital Journal

Internet Pharmacy Warning Letters

 

U.S. Food and Drug Administration (.gov)

https://www.fda.gov › drugs › drug-supply-chain-integrity

4 days ago — Buying prescription drugs from unsafe online pharmacies can be dangerous, or even deadly. FDA recommends that consumers do not purchase prescription drugs from ...

Online sales of obesity drug alternatives carry on despite FDA deadlines June 12, 20255:31 PM ET Heard on All Things Considered By Sydney Lupkin

 Online sales of obesity drug alternatives carry on despite FDA deadlines : NPR

Evolution of the Military Health System compounded drugs utilization and management

 Evolution of the Military Health System compounded drugs utilization and management | Journal of Managed Care & Specialty Pharmacy

US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list

 fidelity.com/news/article/company-news/202506201036RTRSNEWSCOMBINED_L1N3SL0LP_1

FDA’s removal of Ozempic, Wegovy from drug shortage list upheld by Joseph Choi - 06/18/25 3:42 PM ET

Federal judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list

Novo Exits Hims Partnership, Citing Concerns Over Compounded Drugs Story by Naomi Kresge and Madison Muller

 

Novo Exits Hims Partnership, Citing Concerns Over Compounded Drugs